<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this study was to determine whether <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> pregnancies are associated with endothelial cell activation in the maternal circulation </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Markers of endothelial cell activation were measured every 4 weeks during pregnancy in the blood of 23 women with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and 19 control subjects </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> received <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma concentrations of plasminogen activator inhibitor type 1, tissue plasminogen activator, soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1, vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1, E-selectin, and soluble thrombomodulin were determined by enzyme-linked immunoassay </plain></SENT>
<SENT sid="4" pm="."><plain>Concentrations of prothrombin fragments 1+2 and D-dimers were also determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Three <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> pregnancies (13%) were complicated by <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e>; one <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> pregnancy (4%) was complicated by <z:e sem="disease" ids="C0015944" disease_type="Disease or Syndrome" abbrv="PROM">preterm rupture of membranes</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Six women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (26%) had thrombotic events </plain></SENT>
<SENT sid="7" pm="."><plain>Differences in concentrations of endothelial cell activation markers between <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and control pregnancies were not significant </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Despite poorer pregnancy outcome, there was no evidence of greater endothelial cell activation in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> pregnancies that were treated </plain></SENT>
</text></document>